| Serial Number | 97447022 |
| Word Mark | ZEGFROVY |
| Filing Date | Tuesday, June 7, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 14, 2025 |
| Registration Number | 7654958 |
| Registration Date | Tuesday, January 14, 2025 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 27, 2023 |
| Description of Mark | The mark consists of the literal element "ZEGFROVY" to the right of a design consisting of two pairs of differing fanciful geometric shapes intended to depict a gene mutation process. |
| Goods and Services | Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; first-aid boxes, filled; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineral, bath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Translation of Words in Mark | The wording "ZEGFROVY" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 16, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, December 4, 2023 |
| First Use In Commerce Date | Monday, December 4, 2023 |
| Party Name | Dizal (Jiangsu) Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Wuxi City, Jiangsu . CN |
| Party Name | Dizal (Jiangsu) Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Wuxi City, Jiangsu . CN |
| Party Name | Dizal (Jiangsu) Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Wuxi City, Jiangsu CN |
| Event Date | Event Description |
| Wednesday, March 22, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, June 10, 2022 | NEW APPLICATION ENTERED |
| Thursday, June 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 17, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, March 22, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, March 22, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 22, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 22, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 22, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 25, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 7, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 27, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 27, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 22, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 6, 2024 | USE AMENDMENT FILED |
| Tuesday, February 6, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, February 29, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, March 15, 2024 | SU - NON-FINAL ACTION - WRITTEN |
| Thursday, February 29, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, March 15, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, March 15, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 11, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 2, 2024 | ASSIGNED TO LIE |
| Monday, October 28, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, October 28, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, January 14, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 14, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |